TITLE

Oral vitamin K reversed warfarin-associated coagulopathy faster than subcutaneous vitamin K

AUTHOR(S)
Laupacis, Andreas
PUB. DATE
January 2003
SOURCE
ACP Journal Club;Jan/Feb2003, Vol. 138 Issue 1, p10
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on a study that examined the role of oral vitamin K in the reversal of warfarin-associated coagulopathy faster than subcutaneous vitamin K. Description of the clinical characteristics of patients; Patient intervention; Outcome measures.
ACCESSION #
9083220

 

Related Articles

  • Oral Vitamin K Lowers the International Normalized Ratio More Rapidly Than Subcutaneous Vitamin K in the Treatment of Warfarin-Associated Coagulopathy Randomized, Controlled Trial. Crowther, Mark A.; Douketis, James D.; Schnurr, Terri; Steidl, Luigi; Mera, Valentina; Ultori, Carolina; Venco, Achille; Ageno, Walter // Annals of Internal Medicine;8/20/2002, Vol. 137 Issue 4, p251 

    Presents a study regarding the use of oral vitamin K. Focuses on whether oral vitamin K is more effective than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy; Summaries the results of randomized controlled trial of 26 patients.

  • Vitamin K Reverses Overanticoagulation with Warfarin More Quickly When Given by Mouth Than by Injection.  // Annals of Internal Medicine;8/20/2002, Vol. 137 Issue 4, pI-39 

    Presents a summary of the study on the effectiveness of Vitamin K in the treatment of warfarin-associated coagulopathy. Objective of the research; Findings of the researchers; Limitations and implications of the study.

  • Oral vitamin K did not reduce bleeding in patients with excessive anticoagulation after receiving warfarin. Rondina, Matthew // ACP Journal Club;6/23/2009, Vol. 150 Issue 6, p7 

    The article discusses whether oral vitamin K reduces risk for bleeding in patients with warfarin-associated coagulopathy. A randomized placebo-controlled trial was carried out in 14 anticoagulant centers in the U.S., Canada and Italy. The intervention, outcomes and patient follow up of the trial...

  • VITAMIN K & WARFARIN. Barclay, Laurie // Life Extension;Jun2007, Vol. 13 Issue 6, p58 

    The article discusses the health benefits given by vitamin K, a fat soluble vitamin that helps the proper regulation of blood clotting and optimal bone and cardiovascular health. Vitamin K facilitates the control of anticoagulation therapy in patients on long-term treatment with the...

  • Warfarin induced coagulopathy in children: assessment of a conservative approach. Bauman, M. E.; Black, K.; Bauman, M. L.; Kuhle, S.; Bajzar, L.; Massicotte, M. P. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Feb2011, Vol. 96 Issue 2, p164 

    Background Increasing numbers of children are being administered warfarin therapy as thromboprophylaxis. Warfarin has a narrow therapeutic window with a target international normalised ratio (INR) of 2-3.5, called the therapeutic range. The length of time a patient's INR remains within the...

  • Warfarin Overdose: A 25-Year Experience. Levine, Michael; Pizon, Anthony; Padilla-Jones, Angela; Ruha, Anne-Michelle // Journal of Medical Toxicology;Jun2014, Vol. 10 Issue 2, p156 

    Warfarin, a vitamin K antagonist, is widely used for the prophylaxis and treatment of thromboembolic disease. While guidelines exist for management of a supratherapeutic international normalized ratio following therapeutic warfarin use, these guidelines are not designed for management of the...

  • It's in the blood. Allen, Leanne // Nursing Standard;7/7/2004, Vol. 18 Issue 43, p26 

    Provides information about warfarin therapy. Treatment of acquired clotting disorder; Interaction of warfarin with other drugs; Characteristics of Von Willebrand's disease; Physiological role of vitamin K in the treatment of bleeding.

  • Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin. Crowther, Mark A.; Ageno, Walter; Garcia, David; Luqi Wang; Witt, Dan M.; Clark, Nathan P.; Blostein, Mark D.; Kahn, Susan R.; Vesely, Sara K.; Schulman, Sam; Kovacs, Michael J.; Rodger, Marc A.; Wells, Phillip; Anderson, David; Ginsberg, Jeffery; Selby, Rita; Siragusa, Sergio; Silingardi, Mauro; Dowd, Mary Beth; Kearon, Clive // Annals of Internal Medicine;3/3/2009, Vol. 150 Issue 5, p293 

    Background: Low-dose oral vitamin K decreases the international normalized ratio (INR) in overanticoagulated patients who receive warfarin therapy. Its effects on bleeding events are uncertain. Objective: To see whether low-dose oral vitamin K reduces bleeding events over 90 days in patients...

  • Oral Vitamin K Corrects Warfarin Coagulopathy. Walling, Anne D. // American Family Physician;5/1/2001, Vol. 63 Issue 9, p1850 

    Discusses research on the effectiveness of vitamin K in treating warfarin-induced coagulopathy. Reference to a study led by M.A. Crowther which appeared in the November 4, 2000 issue of `Lancet'; Comparison between the active and passive approaches to treatment of warfarin-induced coagulopathy;...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics